Why Your CJC+Ipamorelin Isn't Working on Retatrutide

Your pituitary is not broken. The timing is.

When someone asks how long they should wait to inject CJC and Ipamorelin after eating while on Retatrutide, the honest answer requires understanding two separate systems and what happens when you run them at the same time.

Start with the growth hormone system first, because that is the map you need before the detail makes sense.

Your pituitary gland releases growth hormone in pulses, and those pulses are controlled by two signals from your hypothalamus: something called GHRH, which is a release signal that tells the pituitary to fire, and something called somatostatin, which is a suppression signal that tells it to stop. CJC-1295 mimics GHRH. Ipamorelin mimics a different signal called ghrelin, which both triggers release and suppresses somatostatin at the same time. Together they hit the gas from two angles at once, which is why the stack is popular.

But there is a third player that most people underweight, and that is insulin.

Insulin binds directly to receptors on the somatotroph cells in your pituitary, which are the cells that produce and release growth hormone, and when insulin is elevated it suppresses the amplitude of those pulses. The mechanism is roughly equivalent to someone riding the brake while you press the accelerator. You are creating the signal to release, and insulin is dampening the response before it can build. This is why the standard fasting rule exists. Two hours after eating, insulin has typically returned close to baseline in someone with normal metabolic function, and the brake is released.

That logic holds on its own. The problem is that Retatrutide changes the premise the logic is built on.

Retatrutide is a triple agonist, meaning it activates three receptors: GLP-1, GIP, and glucagon. The GLP-1 activity in particular does something directly relevant here, and that is slowing gastric emptying, which just means food moves out of your stomach and into your small intestine more slowly than it otherwise would. When food moves more slowly, it absorbs more slowly, which means glucose enters your bloodstream more slowly, which means insulin stays elevated longer.

Researchers measured exactly how much this changes the timeline. In a study using semaglutide, which activates the same GLP-1 receptor that the GLP-1 component of Retatrutide activates, the gastric half-emptying time, which is how long it takes for half a meal to leave the stomach, increased from 118 minutes to 171 minutes. That is roughly an extra 53 minutes just to reach the halfway point of emptying. At the two hour mark specifically, participants on the GLP-1 drug had about 25.5 percent more food still sitting in their stomach compared to people not on the drug. And the gap did not shrink at three hours. It widened. At three hours, 38 percent more gastric contents remained compared to placebo.

A separate study on GLP-1 receptor agonist patients found gastric half-emptying of 138 minutes compared to 95 minutes in controls, and patients who had fasted anywhere from 7 to 18 hours still had retained solid gastric contents on imaging. That second finding is what changed fasting protocols for anesthesiologists, who need to be certain a patient's stomach is empty before sedation.

Now run that back through the growth hormone math.

You eat dinner at 7pm. You wait the standard two hours and inject at 9pm, assuming you are in a fasted, low-insulin state. But with Retatrutide slowing your gastric emptying, you are not. You have roughly a quarter of your meal still in your stomach, your gut is still absorbing glucose, your pancreas is still releasing insulin in response, and that insulin is sitting on the pituitary receptors suppressing the very growth hormone pulse you just paid to create. You injected CJC and Ipamorelin into a body that was actively counteracting them.

The compounding problem is that you will not necessarily feel this difference. You might not feel hungry. You might feel like you are in a fasted state. The signal from your stomach is quieter on a GLP-1 drug than it would otherwise be. The physiology and the subjective experience have decoupled, which is what makes this easy to get wrong without knowing it.

There is a specific research note worth adding here. The gastric emptying data above comes from semaglutide and general GLP-1 receptor agonist studies, not from Retatrutide specifically. A 2023 study did confirm that Retatrutide at doses of 3mg and above delayed gastric emptying, measured by pushing back the time it takes for an oral dose to show up in the bloodstream by roughly one hour. So the directional effect is confirmed, and the magnitude is likely in the same range, though the exact numbers from the semaglutide study should not be imported directly without that caveat.

The fix is straightforward. Move your growth hormone peptides to first thing in the morning.

After eight to ten hours of overnight sleep, your stomach has had a full extended window to empty, and even with Retatrutide slowing that process, the total time is sufficient to reach a genuinely fasted state. Your insulin will be at or near its daily low. The brake is off. That is the one fasting window that the gastric emptying effect cannot touch, because it does not compete with a recent meal. It benefits from a window long enough to clear even a slowed system.

One concern people raise about morning versus evening growth hormone peptides is whether timing affects IGF-1 output. A 1990 clinical study in growth hormone-deficient patients compared 24-hour IGF-1 levels between morning and evening injection groups and found them equivalent. The pituitary does not require a specific time of day. It requires a fasted, low-insulin environment. Morning gives you that reliably on Retatrutide. Evenings no longer do.

Then eat your first meal 30 to 60 minutes after injecting. That window lets the growth hormone pulse complete before you introduce carbohydrates and the insulin response that follows. Your liver also needs insulin to convert circulating growth hormone into IGF-1, so eating shortly after injection actually supports the downstream conversion rather than working against it.

The broader point here is not about this one timing error. It is about what happens to your assumptions when you stack compounds. Each drug was characterized in isolation, and the standard rules around each were built on how that drug behaves by itself in an otherwise unmedicated person. When you add a second compound that changes a physiological parameter the first compound depends on, those rules can break without any obvious signal that they have broken.

That is not a reason to avoid stacking. It is a reason to trace the full mechanism before you decide the standard rule still applies.

---

References

1. Urva S, Coskun T, Loghin C, et al. 2023. The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying. Diabetes, Obesity and Metabolism. Finding: Retatrutide at doses ≥3mg delayed acetaminophen Tmax by approximately 1 hour, with effects persisting at Day 30 and Day 79. Source
2. Jensterle M, et al. 2023. Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity. Diabetes, Obesity and Metabolism. Finding: Gastric half-emptying time increased from 118 minutes to 171 minutes on semaglutide. At 2 hours, 25.5% more gastric contents retained vs placebo. At 3 hours, 38% more retained. Source
3. Silveira SQ, et al. 2023. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. Journal of Clinical Endocrinology \& Metabolism. Finding: GLP-1 RA patients had gastric half-emptying of 138 minutes vs 95 minutes on placebo. Patients fasting 7-18 hours still had retained solid gastric contents. Source
4. Jorgensen JO, et al. 1990. Evening versus morning injections of growth hormone in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab. Finding: 24-hour IGF-1 levels were equivalent between morning and evening injection timing. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness